RLAY Competitors & Alternatives
Compare Relay Therapeutics Inc with similar stocks in the same industry
Biotechnology
RLAY
Main Stock$18.41
Tradestie Score
58
Market Cap
$917.23M
Revenue Growth
-0.5%
Analyst Upside
+49.8%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$138.08
|
$3.98B | 134.0 | 66 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$112.63
|
$3.91B | - | 54 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$24.20
|
$3.83B | - | 61 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$16.34
|
$3.68B | - | 49 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$83.44
|
$3.67B | - | 63 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$11.01
|
$3.59B | 16.0 | 27 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$20.19
|
$3.58B | 8.9 | 71 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$314.78
|
$3.49B | 32.3 | 52 | Compare |
More RLAY Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry